A metabolic shift induced by a PPAR panagonist markedly reduces the effects of pathogenic mitochondrial tRNA mutations.
about
Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunitiesScreening for active small molecules in mitochondrial complex I deficient patient's fibroblasts, reveals AICAR as the most beneficial compoundMTO1 mediates tissue specificity of OXPHOS defects via tRNA modification and translation optimization, which can be bypassed by dietary intervention.Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's diseaseRole and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.Mitochondrial biogenesis: a therapeutic target for neurodevelopmental disorders and neurodegenerative diseasesEnhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington's disease.Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial.Bioenergetic medicine.Increases in mitochondrial biogenesis impair carcinogenesis at multiple levels.Pathways for salvage and protection of the heart under stress: novel routes for cardiac rejuvenation.Defining the action spectrum of potential PGC-1α activators on a mitochondrial and cellular level in vivo.Beneficial effects of resveratrol on respiratory chain defects in patients' fibroblasts involve estrogen receptor and estrogen-related receptor alpha signaling.Mitochondria and PGC-1α in Aging and Age-Associated Diseases.
P2860
Q27338799-E333152E-2645-4840-83DE-E47A5BD02649Q28477645-3CA759AA-C0ED-4C22-B1D7-FB40A2E65B49Q35234097-B615A26F-1C68-4F55-ABC4-64A451F5B69FQ35750228-C7550B13-9FB9-4BDC-B078-CF47D774DC34Q35958359-36E31363-F62E-46B5-9DD7-A2E2C25CA23EQ36771650-08785F37-FA09-4CEB-AE53-267564ED66EEQ37368003-E6661AAD-B2BA-4C65-AA82-1380896F097BQ37658358-F165AFAD-CCBC-47B4-9D04-726CF2CA8158Q37686246-EB519DA2-F24B-4F89-B552-5AEA65628FFCQ38594681-EDE156E7-68C7-41D6-9CB1-829E4FBB10ADQ38884029-9A85CC93-CE5D-49C0-A6F2-7FECA2FCB06BQ39295659-41F60EE6-E972-4AF4-8399-B61853B2436AQ42707781-A1FEFB46-0B47-4ADA-84B1-24006D934B70Q42738266-54430492-ED6A-4AE8-8DB7-CF1184518736
P2860
A metabolic shift induced by a PPAR panagonist markedly reduces the effects of pathogenic mitochondrial tRNA mutations.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A metabolic shift induced by a ...... mitochondrial tRNA mutations.
@en
A metabolic shift induced by a ...... mitochondrial tRNA mutations.
@nl
type
label
A metabolic shift induced by a ...... mitochondrial tRNA mutations.
@en
A metabolic shift induced by a ...... mitochondrial tRNA mutations.
@nl
prefLabel
A metabolic shift induced by a ...... mitochondrial tRNA mutations.
@en
A metabolic shift induced by a ...... mitochondrial tRNA mutations.
@nl
P2093
P2860
P1476
A metabolic shift induced by a ...... mitochondrial tRNA mutations.
@en
P2093
Carlos T Moraes
Matteo Marini
P2860
P304
P356
10.1111/J.1582-4934.2010.01223.X
P577
2011-11-01T00:00:00Z